Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2024 08:00 ET | Source: Liquidia Corporation

Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024

Liquidia Corporation to report second quarter 2024 financial results on August 7, 2024.
June 18, 2024 08:42 ET | Source: Liquidia Corporation

Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)

Liquidia to feature two live posters sessions and five encore presentations covering its investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal treprostinil)...
June 03, 2024 07:00 ET | Source: Liquidia Corporation

District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch

Judge Andrews denied the motion for preliminary injunction filed by United Therapeutics that sought to block the launch of Liquidia’s YUTREPIA™.
May 29, 2024 08:00 ET | Source: Liquidia Corporation

Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference

Liquidia Corporation's COO/CFO Michael Kaseta will participate in a fireside chat at the 2024 Jefferies Global Healthcare Conference in NYC.
May 13, 2024 17:43 ET | Source: Liquidia Corporation

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

Liquidia Corporation (NASDAQ: LQDA) today reported financial results for the first quarter ended March 31, 2024.
May 10, 2024 08:00 ET | Source: Liquidia Corporation

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data at the American Thoracic Society (ATS) 2024 International Conference.
May 07, 2024 08:30 ET | Source: Liquidia Corporation

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024

Liquidia Corporation (NASDAQ: LQDA) announced today it will provide an update on the company at the BofA Securities Health Care Conference 2024.
May 07, 2024 08:00 ET | Source: Liquidia Corporation

Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024

Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2024 financial results on May 14, 2024.
April 02, 2024 09:00 ET | Source: Liquidia Corporation

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

MORRISVILLE, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, and Micheal Kaseta,...
April 01, 2024 06:00 ET | Source: Liquidia Corporation

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder

On March 28, Judge Andrews removed the injunction issued in the Original Hatch Waxman LitigationOn March 29, Judge Bates denied United Therapeutics’ motion for temporary restraining order and...